Primary Cardiac Synovial Sarcoma (PCSS): Clinicopathologic Features of 6 Cases and Literature Comparison
Cardiology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/crp/5272035 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, online erschienen am 13.04.2026. Verfasst von Yi-Xiang Cai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhong Shan Hospital (Xiamen Branch), Fudan University, Xiamen, 361015, China, fudan.edu.cn. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Xiamen City, Xiamen University.
Abstract (Originalsprache)
Primary cardiac synovial sarcoma (PCSS) is an exceedingly rare tumor. This study presents a comprehensive analysis of six novel PCSS cases identified within our institutional cohort, compared with published literature cohorts, focusing on their clinical presentations, histopathological features, immunohistochemical and molecular characteristics, therapeutic interventions, and prognosis. Our institutional cohort included five male and one female patients, with a median age of 44 years. Presenting symptoms included dyspnea, chest tightness, back pain, and syncope. Tumors were located in the pericardium (four cases) and the cardiac wall (two cases). The tumor size ranged from 2.0 to 14.5 cm. Histopathologically, four cases were monophasic and two were biphasic. Immunohistochemical analysis revealed consistent expression of TLE1, vimentin, and BCL‐2. Molecular analysis confirmed the presence of the SS18–SSX gene fusion through fluorescence in situ hybridization (FISH) in five cases, whereas one FISH‐negative case was positive for the SS18–SSX1 gene fusion through next‐generation sequencing (NGS). All patients underwent surgical intervention (tumor excision) followed by adjuvant chemotherapy with doxorubicin and ifosfamide. At follow‐up, four patients were alive without disease and two had died. This case series highlights the clinicopathologic and molecular features of PCSS. Overall, SS18 (SYT) gene rearrangement and TLE1 expression are crucial diagnostic markers for differentiating PCSS from other neoplasms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Zhong Shan Hospital (Xiamen Branch), Fudan University, Xiamen, 361015, China, fudan.edu.cn.
- Department of Pathology, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361102, China, xmu.edu.cn.
- Department of Pathology, Zhong Shan Hospital, Fudan University, Shanghai, 200032, China, fudan.edu.cn.
- Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Xiamen, 361015, China.
ORCID-Profile: Hui Li, Xiao-Le Meng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Xiamen City
- Xiamen University
Zitieren
APA
Cai, Y. X., Liu, S. J., Sun, Q., Li, H., & Meng, X. L. (2026). Primary Cardiac Synovial Sarcoma (PCSS): Clinicopathologic Features of 6 Cases and Literature Comparison. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/5272035
Vancouver
Cai YX, Liu SJ, Sun Q, Li H, Meng XL. Primary Cardiac Synovial Sarcoma (PCSS): Clinicopathologic Features of 6 Cases and Literature Comparison. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/5272035
BibTeX
@article{Cai2026,
author = {Cai, Yi-Xiang and Liu, Sheng-Jun and Sun, Qi and Li, Hui and Meng, Xiao-Le},
title = {Primary Cardiac Synovial Sarcoma (PCSS): Clinicopathologic Features of 6 Cases and Literature Comparison},
journal = {Cardiology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crp/5272035}
}
EUVIMED